These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 29594894)

  • 1. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
    Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB/c mice.
    Zhang JX; Zha WS; Ye LP; Wang F; Wang H; Shen T; Wu CH; Zhu QX
    J Appl Toxicol; 2016 Feb; 36(2):271-84. PubMed ID: 26095957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent C5a and C5aR expression in dental pulp cells following stimulation with LTA and LPS.
    Liu M; Mu H; Peng W; Zhao L; Hu W; Jiang Z; Gao L; Cao X; Li N; Han J
    Int J Mol Med; 2019 Sep; 44(3):823-834. PubMed ID: 31257457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
    Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
    J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
    Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
    Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
    Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
    Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
    Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
    Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
    Li Y; Lin F
    Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
    Feng J; Yao W; Zhang Y; Xiang AP; Yuan D; Hei Z
    Cell Physiol Biochem; 2018; 47(2):556-566. PubMed ID: 29794450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
    De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
    Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y; Xu SQ; Long WJ; Zhang XY; Lu HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of C5a receptor in mouse microvascular endothelial cells.
    Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
    J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages.
    Geng Y; Zhang L; Fu B; Zhang J; Hong Q; Hu J; Li D; Luo C; Cui S; Zhu F; Chen X
    Stem Cell Res Ther; 2014 Jun; 5(3):80. PubMed ID: 24961539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.